105 related articles for article (PubMed ID: 22504657)
1. Suppression of intestinal polyp development in Apc(Min/+) mice through inhibition of P-glycoprotein using verapamil.
Fujimoto K; Fujii G; Mutoh M; Yasunaga M; Tanaka H; Wada M
Eur J Cancer Prev; 2013 Jan; 22(1):8-10. PubMed ID: 22504657
[TBL] [Abstract][Full Text] [Related]
2. Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice.
Yamada T; Mori Y; Hayashi R; Takada M; Ino Y; Naishiro Y; Kondo T; Hirohashi S
Cancer Res; 2003 Mar; 63(5):895-901. PubMed ID: 12615699
[TBL] [Abstract][Full Text] [Related]
3. The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice.
Mochida Y; Taguchi K; Taniguchi S; Tsuneyoshi M; Kuwano H; Tsuzuki T; Kuwano M; Wada M
Carcinogenesis; 2003 Jul; 24(7):1219-24. PubMed ID: 12807720
[TBL] [Abstract][Full Text] [Related]
4. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
5. Loss of adiponectin promotes intestinal carcinogenesis in Min and wild-type mice.
Mutoh M; Teraoka N; Takasu S; Takahashi M; Onuma K; Yamamoto M; Kubota N; Iseki T; Kadowaki T; Sugimura T; Wakabayashi K
Gastroenterology; 2011 Jun; 140(7):2000-8, 2008.e1-2. PubMed ID: 21334339
[TBL] [Abstract][Full Text] [Related]
6. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice.
Song J; Sohn KJ; Medline A; Ash C; Gallinger S; Kim YI
Cancer Res; 2000 Jun; 60(12):3191-9. PubMed ID: 10866310
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
Yekkala K; Baudino TA
Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice.
Mutoh M; Niho N; Komiya M; Takahashi M; Ohtsubo R; Nakatogawa K; Ueda K; Sugimura T; Wakabayashi K
Carcinogenesis; 2008 Apr; 29(4):824-9. PubMed ID: 18258607
[TBL] [Abstract][Full Text] [Related]
9. Resistant carbohydrates stimulate cell proliferation and crypt fission in wild-type mice and in the Apc(Min/+) mouse model of intestinal cancer, association with enhanced polyp development.
Mandir N; Englyst H; Goodlad RA
Br J Nutr; 2008 Oct; 100(4):711-21. PubMed ID: 18279550
[TBL] [Abstract][Full Text] [Related]
10. Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways.
Mabley JG; Pacher P; Bai P; Wallace R; Goonesekera S; Virag L; Southan GJ; Szabó C
Mutat Res; 2004 Apr; 548(1-2):107-16. PubMed ID: 15063141
[TBL] [Abstract][Full Text] [Related]
11. Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography.
Hendrikse NH; Schinkel AH; de Vries EG; Fluks E; Van der Graaf WT; Willemsen AT; Vaalburg W; Franssen EJ
Br J Pharmacol; 1998 Aug; 124(7):1413-8. PubMed ID: 9723952
[TBL] [Abstract][Full Text] [Related]
12. beta-Catenin-accumulated crypts in the colonic mucosa of juvenile ApcMin/+ mice.
Hata K; Tanaka T; Kohno H; Suzuki R; Qiang SH; Yamada Y; Oyama T; Kuno T; Hirose Y; Hara A; Mori H
Cancer Lett; 2006 Jul; 239(1):123-8. PubMed ID: 16168560
[TBL] [Abstract][Full Text] [Related]
13. Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production.
Ahn B; Ohshima H
Cancer Res; 2001 Dec; 61(23):8357-60. PubMed ID: 11731407
[TBL] [Abstract][Full Text] [Related]
14. Potential role of P-gp for flavone-induced diminished apoptosis and increased adenoma size in the small intestine of APC(min/+) mice.
Schumacher M; Hautzinger A; Rossmann A; Holzhauser S; Popovic D; Hertrampf A; Oesterle D; Spiller C; Boll M; Wenzel U
Cancer Invest; 2011 Jul; 29(6):396-404. PubMed ID: 21649465
[TBL] [Abstract][Full Text] [Related]
15. Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in Apc(Min/+) Dnmt1-hypomorphic Mice.
Eads CA; Nickel AE; Laird PW
Cancer Res; 2002 Mar; 62(5):1296-9. PubMed ID: 11888894
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin suppresses tumorigenesis in Apc(Min)(/+) mice.
Otani K; Kitayama J; Yasuda K; Nio Y; Iwabu M; Okudaira S; Aoki J; Yamauchi T; Kadowaki T; Nagawa H
Cancer Lett; 2010 Feb; 288(2):177-82. PubMed ID: 19646806
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin.
Rajamanickam S; Velmurugan B; Kaur M; Singh RP; Agarwal R
Cancer Res; 2010 Mar; 70(6):2368-78. PubMed ID: 20215518
[TBL] [Abstract][Full Text] [Related]
18. The CAST/Ei strain confers significant protection against Apc(Min) intestinal polyps, independent of the resistant modifier of Min 1 (Mom1) locus.
Koratkar R; Pequignot E; Hauck WW; Siracusa LD
Cancer Res; 2002 Oct; 62(19):5413-7. PubMed ID: 12359746
[TBL] [Abstract][Full Text] [Related]
19. Intestinal microbiota: a potential diet-responsive prevention target in ApcMin mice.
Mai V; Colbert LH; Perkins SN; Schatzkin A; Hursting SD
Mol Carcinog; 2007 Jan; 46(1):42-8. PubMed ID: 16929480
[TBL] [Abstract][Full Text] [Related]
20. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
Li Q; Ishikawa TO; Oshima M; Taketo MM
Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
